Inokawa et al. found a high level of methylated DNM3 gene promoter and low expression of DNM3 gene in 48 patients with liver cancer, as well as a negative correlation between DNM3 expression in liver cancer tissues and prognosis of the patients, suggesting that DNM3 behaves as a tumor suppressor gene [10]. This evidence concerns the gene DNM3 and liver cancer.